Larvol Delta - Artelo-Biosciences-Accepted-into-the-Alderley-Park-Oncology-Development-Program-for-FABP5-Inhibitor-Biomarker-Development

ART26.12 - SUNY, Artelo Biosci

https://www.globenewswire.com/news-release/2021/03/19/2196263/0/en/Artelo-Biosciences-Accepted-into-the-Alderley-Park-Oncology-Development-Program-for-FABP5-Inhibitor-Biomarker-Development.html

Mar 19, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next